Vivos Therapeutics | 4:持股变动声明-高管 Huntsman Ronald Kirk
Vivos Therapeutics | 4:持股变动声明-高管 Amman Bradford K.
Vivos Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Armistice Capital, LLC(4.99%),Steven Boyd(4.99%)
Vivos Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Ionic Ventures, LLC(1.8%),Ionic Management, LLC(1.8%)等
Vivos Therapeutics | SC 13G:超过5%持股股东披露文件-Ionic Ventures, LLC(8.7%),Ionic Management, LLC(8.7%)等
Vivos Therapeutics | 4:持股变动声明-高管 Huntsman Ronald Kirk
Vivos Therapeutics | 4:持股变动声明-董事 SOKOLOW LEONARD J
Vivos Therapeutics | 4:持股变动声明-董事 Thompson Matthew
Vivos Therapeutics | 4:持股变动声明-董事 Green Ralph Elias
Vivos Therapeutics | 4:持股变动声明-高管 Amman Bradford K.
Vivos Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-R. Kirk Huntsman(4.3%),Coronado V Partners, LLC(3.2%)
Vivos Therapeutics | SC 13G:超过5%持股股东披露文件-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
Vivos Therapeutics | 4:持股变动声明-首席执行官 Huntsman Ronald Kirk
Vivos Therapeutics | 4:持股变动声明-首席执行官 Huntsman Ronald Kirk
Vivos Therapeutics | 4:持股变动声明-首席执行官 Huntsman Ronald Kirk
Vivos Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-R. Kirk Huntsman(9.0%),Coronado V Partners, LLC(6.0%)
Vivos Therapeutics | 4:持股变动声明
Vivos Therapeutics | 4:持股变动声明
Vivos Therapeutics | 4:持股变动声明
Vivos Therapeutics | 4:持股变动声明